Between 2020 and 2035, the North America IVD Quality Control Market is expected to register steady growth. The market was valued at 1,120 Million USD in 2020, rose to 1,450 Million USD in 2025, and is projected to reach 2,900 Million USD by 2035. This trend is attributed to continued healthcare investment, regulatory enforcement, and rising demand for advanced diagnostics across healthcare settings. Industry growth is supported by sustained technological innovation and heightened awareness about quality standards, ensuring robust expansion through the forecast period.
Clinical Chemistry is projected to hold the largest share (30%) of the market in 2025, highlighting its foundational significance in laboratory diagnostics. Immunochemistry follows at 24%, fueled by increased testing for infectious and chronic diseases. Molecular Diagnostics sees a significant share at 20%, reflecting the shift towards genetic and pandemic-related testing. Hematology constitutes 14% of the market, while Coagulation and Microbiology collectively total 12%. The rising molecular diagnostics segment demonstrates demand for advanced QC tailored to new testing modalities, while immunochemistry's broad use in disease screening sustains its robust presence.
Request Free Sample- https://bussinessinsights.com/request/healthcare/north-america-in-vitro-diagnostics-(ivd)-quality-control-market
Who are the key players in North America In Vitro Diagnostics (IVD) Quality Control Market industry?
The top 5 players in the North America IVD Quality Control Market include Bio-Rad Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Roche Diagnostics, and Abbott Laboratories. These companies offer extensive quality control products, innovative technologies, and robust distribution networks, maintaining a significant industry presence and driving ongoing advancements.
What is the North America In Vitro Diagnostics (IVD) Quality Control Market growth?
The North America IVD Quality Control Market is experiencing robust growth, driven by increasing laboratory automation and rising demand for reliable diagnostic tests. For example, Bio-Rad Laboratories’ recent launch of advanced QC solutions accelerates market adoption and supports faster, more accurate diagnostics across hospitals and laboratories.
Which segment accounted for the largest North America In Vitro Diagnostics (IVD) Quality Control Market share?
Clinical chemistry applications account for the largest share in the North America IVD Quality Control Market, due to their crucial role in disease diagnosis and patient monitoring. Growing use of quality control measures in routine blood and biochemical tests in hospitals and reference labs sustains this segment’s dominance.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com